Lecanemab is being heavily promoted for treatment of minimal cognitive impairment (MCI) and early Alzheimer disease (AD) dementia. But recent data support consideration of low-dose lithium for this role and for primary prevention of cognitive…
Lecanemab or Lithium for Alzheimer Disease Dementia? New Data Change Everything
